A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop to explore the potential applications of AI as a tool in regenerative medicine throughout the product development pipeline. The overarching goal of this workshop is to consider the opportunities and challenges with using AI to enhance the translation of regenerative medicine therapies.
The public workshop may include invited presentations and discussions to:

• Explore how AI can be used to improve the discovery of regenerative medicine therapies and the development of related technologies that improve therapeutic efficacy.
• Consider the applications of AI with pre-clinical models in translational research to more effectively optimize these systems and analyze large data sets derived from these systems, including opportunities to provide supplemental nonclinical data.
• Examine the potential uses of AI to support regenerative medicine clinical trials and regulatory processes by understanding the role of AI in informing innovative trial designs and predicting and evaluating clinical outcomes, such as in pharmacovigilance.
• Explore the growing opportunities to leverage AI in the manufacturing process for regenerative medicine products, including in combination with other advanced biomanufacturing methods.
• Discuss the ethical and legal implications for AI in regenerative medicine and the ways AI can improve safe and effective regenerative medicine therapies.

The planning committee will organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A proceedings - in brief of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.